Open Access Article
Léo
Chaussy‡
,
Marion
Delorme‡
,
Alexander
Punter
,
Yannick
Carissan
,
Jean-Luc
Parrain
,
Muriel
Amatore
*,
Paola
Nava
* and
Laurent
Commeiras
*
Aix Marseille Univ, CNRS, Centrale Marseille, iSm2, Marseille, France. E-mail: laurent.commeiras@univ-amu.f; paola.nava@univ-amu.fr; muriel.amatore@univ-amu.fr
First published on 21st September 2023
The molecular complexity of recently reported cobalt(III) polycyclic complexes, resulting from an intramolecular formal (2 + 2 + 3) cycloaddition reaction on an enediyne containing a lactone moiety, has prompted us to computationally review the mechanisms of cobalt cycloaddition reactions with γ-alkylidenebutenolide or γ-alkylidenebuterolactam as 2π partners. Computed mechanisms are compared, leading to either cobalt(III)- or cobalt(I)-spiro complexes depending of both the nature of the reaction (intra- vs. intermolecular pathway) and the nature of the 2π partner (γ-alkylidenebutenolide vs. γ-alkylidenebuterolactam). These proposed mechanisms are supported by experiments, allowing us to report the synthesis and characterization of the predicted compounds.
The molecular complexity of these unprecedented cobalt(III) complexes pushed us to perform further theoretical calculations by comparing intra- versus intermolecular approaches (Fig. 1a), and by computing the outcomes of a related Co(I)-mediated reaction employing γ-alkylidenebuterolactam as 2π partner, instead of γ-alkylidenebutenolide (Fig. 1b). The computational studies are systematically supported by experiments, which enable us to report the synthesis of new compounds.
In the intermolecular reactivity, four coordination approaches are possible between the cobaltacyclopentadiene and the two double bonds of the γ-alkylidenebutenolide (Fig. 2): either the exo- and endo-approaches with the exo-cyclic double bond, or the exo- and endo-approaches with the endo-cylic double bond. The energy of IIexo was chosen as reference.
From IIexo (Fig. 3 left), two regioselectivities can be envisioned for the insertion step of the exo-cyclic double bond: either the C2–C10 bond is formed to provide IIIexo1 (orange path), preventing the formation of the diketone product, or the C8–C9 bond is created to obtain IIIexo2 (blue path). By following the orange pathway, intermediate IIIexo1 evolves to the spirolactone P2exo product through a transition state located at only 13.7 kcal mol−1. The transition state leading to IIIexo2 is sterically more accessible and thus lower in energy (7.8 kcal mol−1) than the one leading to IIIexo1 (10.5 kcal mol−1). This accessibility results in intermediates that are significantly different in energy, with IIIexo2 more stable. From IIIexo2 two pathways can be considered: a reductive elimination step implicating the formation of the C2–C10 bond, would lead to the spirolactone P2exo product, while the creation of the C2–C11 bond would cause the spontaneous fragmentation of the lactone. Two further steps are necessary to obtain the Co(III) complex P1exo. These two transition states are similar in energy, however barriers from IIIexo2 are quite high. Therefore, overall, even if the insertion step apparently would favour the process through IIIexo2, the approach through IIIexo1 is preferred, thus excluding the possibility to form P1exo.
In the pathway resulting from an endo approach (Fig. 3 right), two different insertion positions are again formally possible, with the creation of either the C2–C10 bond to IIIendo1 (orange path), or the C8–C9 bond to IIIendo2 (blue path). In both cases, only the spirolactone P2endo product could be obtained. The obtention of the Co(III) complex would require the formation of the C2–C11 bond. However, in IIIendo2 the C11 is not correctly positioned face to C2. As for the exo approach, even if the insertion step is less accessible from the lactone side (orange path), the pathway through this approach is overall favoured, as the barrier for the reductive elimination is significantly lower.
We also computationally studied the coordination of the cobaltacyclopentadiene with the endo-cyclic double bond of the γ-alkylidenebutenolide (II′exo and II′endo, Fig. 2). The system evolves towards the coordination of the cobaltacyclopentadiene with the exo-cyclic double bond of the 2π partner.
Our calculations demonstrate that the Co(III) complex is not accessible in the intermolecular version of the reaction. The overall costs to the γ-spiro-γ-lactone products P2exo and P2endo are similar: the highest transition states are located at 13.7 and 14.4 kcal mol−1 (less than 1 kcal mol−1 difference) for the exo and endo approaches, respectively, suggesting that the two products could be obtained. In both cases the insertion step through the lactone side (orange path) leads to an intermediate with an accessible transition state for the reductive elimination step, preventing the possibility to form the β-oxo-ketene intermediate. This is not the case in the intramolecular approach. The presence of the tether between the diyne and the γ-alkylidenebutenolide facilitates the coordination of the alkene moiety by imposing an exo-like approach (Scheme 1). The resulting intermediate III has a connectivity similar to that of IIIexo2, which differs from that of IIIexo1. Importantly, only a connectivity as in IIIexo2 allows to access to the Co(III) complex (see ESI† for details on the structures).
Experiments were then performed to corroborate the computational studies. Slightly reoptimized conditions developed for the intramolecular formation of Co(III) complex were applied for the intermolecular strategy (Scheme 2). The diyne partner 1a (1 equiv.) and the γ-alkylidenebutenolide 2a (3 equiv.) were exposed to a stoichiometric amount of CpCo(CO)2 (1.2 equiv.) in toluene (0.25 mol L−1) at 110 °C under irradiation (halogen 400 W) for one night. In these conditions, the formation of the predicted tricyclic spirolactone cobalt(I) complex 3a was observed and isolated in 45% yield as a 1
:
0.2 mixture of two diastereomers. As the γ-alkylidenebutenolide employed displays two methyl substituents, it slightly differs from the lactone in Fig. 3. Calculations were therefore performed with the doubly substituted substrate, as well. The computed profiles (in the ESI†) are sensibly the same as those reported in Fig. 3, allowing to draw the same conclusion. The formation of the γ-spiro-γ-lactone cobalt complex is thus favoured over that of the Co(III) complex and the experimental result validates the conclusions of the theoretical study.
To enhance the synthetic potential of this tricyclic spirolactone cobalt complex 3a, we then investigated its oxidative demetallation. When 3a is submitted to 1 equivalent of FeCl3·6H2O in acetonitrile, carboxylic acid 4a was isolated in 80%, instead of the expected γ-spiro-γ-lactone compound. The formation of 4a could be explained by a β-elimination step, after the decomplexation of the cobalt, which is favoured by the aromatisation of the 6-membered ring. It is worth noting that 4a could be obtained in similar yield (33%), without the purification of the spirolactone cobalt complex 3a. Finally, the indanone 5a could be obtained in 68% yield when 4a is treated with an excess of oxalyl chloride.
This sequential three-step synthesis was applied with two other diynes (Z = NTs and Z = O), providing the corresponding indenones 5b–5c in 20 and 16% yields respectively.
![]() | ||
| Fig. 4 Model reactivity. ‘Starting’ denotes the initial structures and ‘Optimised’ denotes the structure obtained after the geometry optimisations (PBE0/def2-TZVP). | ||
One the one hand, the Lewis structure of the lactone-derived system (Fig. 4c) displays an oxygen atom carrying a positive charge and the other oxygen atom carrying a negative charge. This charge separation suggests that it would not be stable. Indeed, a geometry optimisation was performed, and a spontaneous cleavage of the C–O bond is observed (Fig. 4e). On the other hand, the Lewis structure for the lactam-derived system (Fig. 4d) presents a charge separation, which is compatible with the electronegativity of the atoms, the nitrogen atom being formally charged plus and the oxygen minus. The geometry optimisation did not show the cleavage of the C–N bond (Fig. 4f). In this case, the fragmentation of the lactam ring is not spontaneous, which suggests that its transformation to β-imino-ketene moiety is less accessible than for the lactone moiety.
To verify this hypothesis, the mechanisms of the [2 + 2 + 2] cycloaddition reactions with a lactam moiety have been compared to those obtained with the lactone (Fig. 5). For clarity reason, we report on top of Fig. 5 the computed mechanism for the lactone case. The overall picture of this mechanism is the same as the one presented in Scheme 1 and previously reported, although ΔG values differ slightly, since we employ here a different level of calculations (see the computational details).6 Moreover, we have detailed in the present work the coordination step from IIaO to IIO through TsOII that was not reported in our previous contribution.
Let us now describe the computed pathways for the lactam case. From IN, the pathway would be the following: the oxidative coupling takes place leading to IIaN in a singlet state. The triplet state of IIaN is lower in energy (ΔΔG = ΔG(1IIaN) − ΔG(3IIaN) = 5.2 kcal mol−1), however the coordination of the alkene moiety to the metal is not possible on the triplet potential energy surface, while this coordination is readily accessible on the singlet state to IIN. The insertion step would give IIIN.
From IIIN, the two pathways are considered. Notably, the transition state leading to the γ-spiro-γ-lactam cobalt complex (TsNIII-P2 to P2N) is slightly lower than the one leading to the formation of the C2–C14 bond (TsNIII-IV to IVN). Interestingly and as predicted by the model (Fig. 4), the lactam ring does not open after TsNIII-IV to IVN. The following transformation, implying the fragmentation of the lactam moiety, would give an intermediate that is 11.7 kcal mol−1 higher than IVN and the transition state leading to the hypothetical Co(III) product (TsNV-P1 to P1N) is even higher than TsNIII-IV.
Finally, in the case of the lactam, the mechanisms of the [2 + 2 + 2] cycloaddition reaction is preferred over that leading to the P1N product. The overall ΔG profiles differ from those computed for the lactone, where the 5-membered ring fragments immediately after the formation of the C2–C14 bond. Notably VO would be only 4.9 kcal mol−1 higher in energy than IVO and the last transition state (TsOIII-IV) is lower than TsOIII-IV (Fig. 5).
The intramolecular [2 + 2 + 2] cycloaddition reaction of the ene-1,6-diyne containing a lactam scaffold, was then explored to validate the computational study (Scheme 3). The benchmark substrate 8 was prepared as a partially separable mixture of E/Z isomers.8 After separation, each enriched diastereomer was submitted to the same reaction conditions as those for the intramolecular [2 + 2 + 2] cycloaddition reaction with a lactone scaffold (1.2 equiv. of CpCo(CO)2 in toluene at 110 °C during 16 hours under irradiation (halogen 400 W)). Pleasingly, as predicted by the theoretical study, the cycloaddition reaction proceeded stereospecifically to give the desired γ-spiro-γ-lactam cobalt complexes 9-cis and 9-trans, even with no full conversion. It is interesting to note an erosion of the stereospecificity of the cycloaddition reaction, which could be explained by the partial isomerization of the exo-cyclic double bond of the lactam moiety under the reaction conditions.
As the benchmark substrate 8 exists in the Z and E form, calculations were also performed on the latter. The computed mechanism shows that only a spiro product can be obtained from the E isomer, as detailed in the ESI.†
The mechanism for the lactone substrate in Fig. 5 was newly calculated to provide comparable results with those proposed in this contribution. Results between calculations performed at the BP86-D3 level (the method used in our preliminary work)6 and those obtained at the TPSS-D3 level here reported are almost identical. However, we decided to systematically employ the TPSS-D3 functional because it belongs to the meta-GGA functional family, which represents an improvement over the GGA functionals (as BP86). The TPSS functional is a general purpose functional that works well for transition metal complexes (notably 3d metals)10f and provides, as well, good results on the energetics of cobalt complexes, when comparing singlet and triplet states. Singlet and triplet potential energy surfaces get close for some intermediates of the cobalt-catalysed or mediated cycloaddition reactions, although we focused in this work on steps occurring on the singlet potential energy surface. We employ here the TPSS-D3 functional because it provides the triplet vs. singlet energy ordering predicted by ab initio calculations, whereas methods as B3LYP or PBE0 tend to over-stabilise triplets in some cases, in particular for the insertion intermediate.5
The lactam reaction pathway was computed by three different DFT methods (BP86-D3,10a,b,e,13 TPSS-D3, PBE0-D3 functionals,10a,b,e,14 def2-TZVP basis set, see ESI†). Importantly, all computations deliver the same qualitative picture, predicting that the pathway to the Co(III) complex is less favoured than the one to the spirocyclic lactam Co(I) complex. However, relative energies are somewhat sensitive to the method used, notably the difference in energy between IIIN and IIN is of −3.0 kcal mol−1 at the TPSS-D3 level and decreases to −10.3 kcal mol−1 at the PBE0-D3 level. We have then checked that the TPSS-D3 method would provide reasonable results: we considered the model systems for the cobaltacyclopentadiene coordinated by an alkene, IImod, and for the intermediate following the insertion, IIImod. The energy differences (ΔE = EIIImod − EIImod, without ZPE, gas phase) between these complexes, computed at DFT (BP86-D3, TPSS-D3, PBE0-D3 functionals, def2-TZVP basis set) and CCSD(T) levels, are reported in Table 1. CCSD(T) calculations, performed with the MOLPRO program package, are single point calculations on TPSS structures and employ the aug-cc-pwCVTZ-DK, cc-pVTZ-DK and cc-pVDZ-DK basis sets for Co, C and H, respectively. Results from TPSS-D3 and BP86-D3 are close to the CCSD(T) value (within 1.6 kcal mol−1), whereas the PBE0 method predicts the insertion intermediate somewhat too stable than IImod. We concluded that the TPSS-D3 calculations would give a more accurate global picture of the treated mechanisms than the hybrid GGA (Generalized Gradient Approximation) PBE0 functional in these cases.
Infra-red spectra were recorded on a Bruker VERTEX70 Fourier transform infrared spectrometer fitted with a single reflection diamond ATR Bruker A222 accessory. The measurements were done for pure samples. For each individual spectrum, about 30 scans were averaged at 4 cm−1 resolution. The diamond crystal without sample served as reference. All the system was purged with dry air. The identification of peaks was done with the standard method proposed in OPUS 6.0 software. Wavelengths of maximum absorbance (max) are quoted in cm−1.
High resolution MS experiments were performed with a QSTAR Elite mass spectrometer (Applied Biosystems SCIEX) or a SYNAPT G2 HDMS mass spectrometer (Waters) equipped with an electrospray ionization source operated in the positive ion mode. In this hybrid instrument, ions were measured using an orthogonal acceleration time-of-flight (oa-TOF) mass analyzer.
Analytical thin layer chromatography (TLC) was carried out on Merck® Kieselgel 60 F254 plates and achieved under a 254 nM UV light, visualized with a KMnO4 solution or anisaldehyde solution.
:
1) to give 3a as 1/0.2 mixture of diastereomers (28 mg, 45% yield). Major diastereomer: mp 159 °C; 1H NMR (300 MHz, chloroform-d) δ 0.89 (s, 3H), 1.11 (br d, J = 15.8 Hz, 1H), 1.29 (br s, 3H), 1.36 (br q, J = 1.0 Hz, 3H), 1.69 (br q, J = 1.0 Hz, 3H), 1.92 (d, J = 15.8 Hz, 1H), 3.13 (d, J = 16.4 Hz, 1H), 3.17 (d, J = 16.4 Hz, 1H), 3.67 (d, J = 16.4 Hz, 1H), 3.69 (d, J = 16.4 Hz, 1H), 3.80 (s, 3H), 3.89 (s, 3H), 4.48 (s, 5H); 13C NMR (75 MHz, chloroform-d) δ 8.5, 10.3, 16.4, 23.5, 39.0, 39.4, 44.2, 53.2, 53.4, 55.9, 56.2, 60.2, 82.8 (5C), 94.5, 94.7, 94.9, 122.5, 161.1, 172.4, 173.0, 174.5; HRMS (ESI-MS) calcd for C25H30O6Co+ [M + H]+ 485.1369, found 485.1364; IR νmax/cm−1 2956, 1735, 1436, 1257, 1199, 116.
:
1 to 8
:
2) to give 4a (12 mg, 80% yield). Mp 171 °C; 1H NMR (300 MHz, chloroform-d) δ 1.99 (br q, J = 1.1 Hz, 3H), 2.02 (br q, J = 1.1 Hz, 3H), 2.03 (s, 3H) 2.17 (s, 3H), 3.54 (s, 4H), 3.75 (s, 3H), 3.77 (s, 3H), 6.61 (s, 1H), OH not observed; 13C NMR (75 MHz, chloroform-d) δ 15.8, 15.9, 18.7, 23.3, 39.9, 40.3, 53.1 (2C), 59.6, 125.0, 126.6, 127.1, 130.9, 137.6, 139.2, 142.3, 147.8, 171.2, 172.4, 172.7; HRMS (ESI-MS) calcd for C20H28NO6+ [M + NH4]+ 378.1911, found 378.1914; IR νmax/cm−1 2010, 1726, 1658, 1433, 1280, 1255, 1190, 1155, 1076, 1057.
:
2) to give 5a (6.5 mg, 68% yield). Mp 198 °C; 1H NMR (400 MHz, chloroform-d) δ 1.74 (br q, J = 1.6 Hz, 3H), 2.23 (br q, J = 1.6 Hz, 3H), 2.31 (s, 3H), 2.40 (s, 3H), 3.49 (s, 2H), 3.51 (s, 2H), 3.77 (s, 6H); 13C NMR (101 MHz, chloroform-d) δ 7.6, 13.7, 15.8, 16.0, 39.3, 40.4, 53.2 (2C), 59.2, 125.2, 127.8, 130.9, 131.4, 139.8, 143.2, 144.9, 154.1, 172.2 (2C); 199.4; HRMS (ESI-MS) calcd for C20H23O5+ [M + H]+ 343.1540, found 343.1541; IR νmax/cm−1 1734, 1693, 1429, 1265, 1065, 1159, 1080, 1049.
:
1 to 8
:
2). Mp 140 °C; 1H NMR (300 MHz, chloroform-d) δ 1.74 (br q, J = 1.3 Hz, 3H), 2.22 (br q, J = 1.3 Hz, 3H), 2.24 (s, 3H), 2.32 (s, 3H), 2.41 (s, 3H), 4.45–4.61 (m, 4H), 7.33 (d, J = 8.5 Hz, 2H), 7.78 (d, J = 8.5 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 7.5, 13.5, 15.6, 15.9, 21.7, 53.4, 54.1, 123.7, 127.7 (2C), 128.4, 129.4, 130.1 (2C), 132.0, 134.1, 136.3, 141.1, 143.8, 143.9, 153.8, 198.7; HRMS (ESI-MS) calcd for C22H24NO3S [M + H]+ 382.1471 found 382.1468; IR νmax/cm−1 2360, 1689, 1631, 1352, 1161, 1099.
:
5 to 8
:
2). 1H NMR (300 MHz, chloroform-d) δ 1.76 (br q, J = 1.3 Hz, 3H), 2.25 (br q, J = 1.3 Hz, 3H), 2.27 (s, 3H), 2.37 (s, 3H), 5.07 (s, 4H); 13C NMR (75 MHz, chloroform-d) δ 7.5, 13.9, 15.9, 16.0, 73.9, 74.3, 122.7, 128.4, 128.5, 131.7, 139.1, 143.8, 144.2, 153.9, 199.1; HRMS (ESI-MS) calcd for C15H17O2+ [M + H]+ 229.1223, found 229.1223; IR νmax/cm−1 2922, 1685, 1471, 1375, 1055, 906.
:
1 to 8
:
2) to give the corresponding hydroxylactam 7 (166 mg, 62% yield). 1H NMR (300 MHz, chloroform-d) δ 0.94 (t, J = 7.3 Hz, 3H), 1.24 (q, J = 7.0 Hz, 3H), 1.25 (q, J = 7.0 Hz, 3H), 1.35 (sixt, J = 7.5 Hz, 2H), 1.57–1.70 (m, 2H), 1.74 (br t, J = 2.5 Hz, 3H), 2.01 (br d, J = 1.6 Hz, 3H), 2.11–2.21 (m, 1H), 2.28–2.38 (m, 1H), 2.42 (s, 3H), 2.64–2.82 (m, 6H), 3.03–3.13 (m, 1H), 3.40–3.50 (m, 1H), 3.95–4.2 (m, 6H), 5.76 (br q, J = 1.6 Hz, 1H), 7.29 (d, J = 8.4 Hz, 2H), 7.61 (d, J = 8.4 Hz, 2H), OH not observed; 13C NMR (75 MHz, CDCl3) δ 3.6, 12.1, 13.9, 14.2 (2C), 20.7, 21.7, 22.9, 23.1, 31.6, 32.5, 38.0, 38.8, 42.0, 56.6, 62.1 (2C), 73.0, 76.6, 79.3, 80.7, 91.9, 123.1, 127.5 (2C), 129.9 (2C), 135.9, 143.9, 158.8, 169.0 (2C), 169.8; HRMS (ESI-MS) calcd for C33H45N2O8S [M + H]+ 629.2891 found 629.2892; IR νmax/cm−1 2954, 1732, 1683, 1355, 1327, 1290, 1197, 1153, 1087, 1047, 723, 663, 576.
:
EtOAc 8
:
2) to give both enriched diastereomers (m ((Z)-8 + (E)-8) = 299 mg, 96% yield). HRMS (ESI-MS) calcd for C33H43N2O7S [M + H]+ 611.2786 found 611.2789.
(Z)-8: 1H NMR (300 MHz, chloroform-d) δ 0.91 (t, J = 7.3 Hz, 3H), 1.21 (t, J = 7.1 Hz, 6H), 1.25–1.37 (m, 2H), 1.45–1.56 (m, 2H), 1.72 (br t, J = 2.4 Hz, 3H), 1.97 (br d, J = 1.5 Hz, 3H), 2.43 (s, 3H), 2.67 (br q, J = 2.4 Hz, 2H), 2.73 (br t, J = 2.1 Hz, 2H), 3.69 (dd, J = 7.3 Hz, 2H), 4.08–4.26 (m, 8H), 4.98 (t, J = 7.0 Hz, 1H), 5.85 (br q, J = 1.5 Hz, 1H), 7.32 (d, J = 7.9 Hz, 2H), 7.70 (d, J = 7.9 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 3.6, 12.4, 13.9, 14.1 (2C), 20.0, 21.7, 22.8, 23.0, 32.0, 37.3, 40.7, 43.4, 56.6, 62.0 (2C), 73.0, 76.0, 79.2, 81.3, 104.8, 120.5, 127.8 (2C), 129.8 (2C), 136.0, 141.9, 144.0, 148.5, 168.9 (2C), 170.9; IR νmax/cm−1 1728, 1357, 1296, 1199, 1159, 1089, 1051, 894, 752, 655.
(E)-8: 1H NMR (300 MHz, chloroform-d) δ 0.89 (t, J = 7.2 Hz, 3H), 1.20 (t, J = 7.1 Hz, 6H), 1.18–1.30 (m, 2H), 1.34–1.47 (m, 2H), 1.72 (t, J = 2.5 Hz, 3H), 2.29 (br d, J = 1.6 Hz, 3H), 2.43 (s, 3H), 2.67 (br q, J = 2.5 Hz, 2H), 2.74 (br t, J = 2.3 Hz, 2H), 3.44 (t, J = 7.2 Hz, 2H), 4.05–4.19 (m, 6H), 4.23 (d, J = 7.6 Hz, 2H), 5.14 (t, J = 7.6 Hz, 1H), 5.93 (br q, J = 1.6 Hz, 1H), 7.28–7.37 (d, J = 7.9 Hz, 2H), 7.64–7.76 (d, J = 7.9 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 3.5, 13.9, 14.1 (2C), 16.8, 20.2, 21.7, 22.8, 23.0, 30.8, 36.9, 38.6, 43.2, 56.5, 61.9 (2C), 73.0, 76.1, 79.1, 81.1, 107.3, 124.7, 127.7 (2C), 129.8 (2C), 136.2, 142.2, 143.9, 145.7, 168.8 (2C), 168.9; IR νmax/cm−1 2960, 1743, 1689, 1352, 1205, 1159, 1085, 1057.
:
0.07 inseparable mixture of 9-cis and 9-trans (16 mg, 58% yield, 62% yield, 71% of conversion). 1H NMR (300 MHz, chloroform-d) δ 0.69 (s, 3H), 1.17 (t, J = 6.9 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H), 1.32–1.36 (m, 7H), 1.41–1.70 (m, 4H), 2.20–2.35 (m, 1H), 2.45 (s, 3H), 3.10–3.66 (m, 9 H), 4.12 (s, 5H), 4.25 (q, J = 7.1 Hz, 2H), 4.35 (br q, J = 7.1 Hz, 2H), 5.59 (br q, J = 1.6 Hz, 1H), 7.42 (d, J = 8.1 Hz, 2H), 7.82 (d, J = 8.1 Hz, 2H); 13C NMR (75 MHz, chloroform-d) δ 12.6, 14.2, 14.3 (2C), 17.5, 21.6, 21.7, 30.2, 39.4, 40.1, 44.0, 48.7, 51.4, 53.6, 59.4, 60.5, 62.4, 62.6, 63.7, 84.0 (5C), 89.8, 95.2, 121.4, 127.9 (2 C), 130.0 (2 C), 134.0, 144.2, 160.6, 171.7, 172.2, 173.4 (one quaternary C carbon is in CDCl3peaks); HRMS (ESI-MS) calcd for C38H48N2O7SCo [M + H]+ 735.2509, found 735.2509; IR νmax/cm−1 2960, 2927, 1726, 1685, 1342, 1246, 1161, 1101, 1045, 1008, 802, 673.
:
0.09 inseparable mixture of 9-cis and 9-trans (29 mg, 69% yield, 90% of conversion). 1H NMR (300 MHz, chloroform-d) δ 0.77 (s, 3H), 0.83 (t, J = 7.0 Hz, 3H), 1.09–1.20 (m, 3H), 1.20–1.27 (m, 1H), 1.30 (t, J = 7.1 Hz, 3H), 1.36 (t, J = 7.1 Hz, 3H), 1.41–1.51 (m, 1H), 2.26–2.38 (m, 1H), 2.43 (s, 3H), 2.53 (br d, J = 1.5 Hz, 3H), 2.60–2.73 (m, 1H), 3.08 (d, J = 17.0 Hz, 1H), 3.16 (br s, 2H), 3.34 (br dd, J = 7.8 and 8.6 Hz, 1H), 3.45 (d, J = 17.0 Hz, 1H), 3.55 (d, J = 17.0 Hz, 1H), 3.68–3.73 (m, 1H), 3.73 (d, J = 17.0 Hz, 1H), 4.23 (s, 5H), 4.23–4.39 (m, 4H), 5.82 (br q, J = 1.5 Hz, 1H), 7.39 (d, J = 8.3 Hz, 2H), 7.75 (d, J = 8.3 Hz, 2H); 13C NMR (75 MHz, chloroform-d) δ 13.9, 14.2, 14.3, 17.8, 17.9, 20.5, 21.7, 30.8, 39.3, 39.7, 39.8, 49.4, 50.9, 53.2, 56.5, 59.8, 60.1, 62.4, 62.6, 77.5, 84.0 (5C), 89.7, 95.2, 126.3, 127.7 (2 C), 130.0 (2C), 134.1, 144.1, 158.2, 169.6, 171.7, 171.9; HRMS (ESI-MS) calcd for C38H48N2O7SCo [M + H]+ 735.2509, found 735.2509; IR νmax/cm−1 1734, 1687, 1348, 1259, 1182, 1151, 1093, 1051, 1010, 823, 673.
Footnotes |
| † Electronic supplementary information (ESI) available: Additional computations, computational details, 1H and 13C NMR spectra of each compound, computed coordinates. See DOI: https://doi.org/10.1039/d3dt02291a |
| ‡ These authors contributed equally. |
| This journal is © The Royal Society of Chemistry 2023 |